I propose to take Questions Nos. 416 and 417 together.
As the Deputy is aware, methadone is a Schedule 2 controlled drug under the Misuse of Drugs Regulations 1988 which means that strict prescription, recording and storage requirements apply. Further requirements are set out under the Misuse of Drugs (Supervision of Prescription and Supply of Methadone) Regulations 1998 made under the Misuse of Drugs Act 1977 reflecting the fact that it is most commonly used in treatment programmes for opiate dependency.
Responsibility for the provision of opioid substitution treatment, mainly methadone, rests with the Health Service Executive. All patients in receipt of methadone maintenance treatment are recorded on the HSE Central Treatment List, and treatment delivery is monitored in accordance with the Methadone Treatment Protocol. The aim of this Protocol is to manage the distribution of methadone and minimise the risk of diversion for onward sale.
I have asked the HSE to respond directly in relation to the specific issues raised by the Deputy.